|
2025-01-27 |
2025-01-24 |
S
Sale
|
Wall Brett A.
EVP & Pres Neuroscience
Officer
|
12,437
-23.3%
90.00
USD 1,119,330
|
12,437
-23.3%
|
90.00
|
USD 1,119,330
|
|
|
2025-01-10 |
2025-01-08 |
S
Sale
|
Wall Brett A.
EVP & Pres Neuroscience
Officer
|
3,000
-6.9%
80.41
USD 241,230
|
3,000
-6.9%
|
80.41
|
USD 241,230
|
|
|
2025-01-10 |
2025-01-08 |
S
Sale
|
Wall Brett A.
EVP & Pres Neuroscience
Officer
|
6,850
-13.5%
80.41
USD 550,809
|
6,850
-13.5%
|
80.41
|
USD 550,809
|
|
|
2024-06-11 |
2024-06-07 |
S
Sale
|
Martha Geoffrey
Chairman and CEO
Executive Director
|
1,594
-1.1%
83.82
USD 133,609
|
1,594
-1.1%
|
83.82
|
USD 133,609
|
|
|
2024-06-11 |
2024-06-07 |
S
Sale
|
Martha Geoffrey
Chairman and CEO
Executive Director
|
17,519
-10.8%
83.76
USD 1,467,391
|
17,519
-10.8%
|
83.76
|
USD 1,467,391
|
|
|
2024-04-09 |
2024-04-08 |
S
Sale
|
Marinaro Michael
EVP & President, Surgical OU
Officer
|
854
-3.0%
83.14
USD 71,002
|
854
-3.0%
|
83.14
|
USD 71,002
|
|
|
2024-02-23 |
2024-02-21 |
S
Sale
|
Salmon Sean
EVP & President Cardiovascular
Officer
|
16,035
-24.9%
85.12
USD 1,364,899
|
16,035
-24.9%
|
85.12
|
USD 1,364,899
|
|
|
2024-02-23 |
2024-02-21 |
S
Sale
|
Salmon Sean
EVP & President Cardiovascular
Officer
|
13,066
-16.9%
85.15
USD 1,112,570
|
13,066
-16.9%
|
85.15
|
USD 1,112,570
|
|
|
2024-02-23 |
2024-02-21 |
S
Sale
|
Salmon Sean
EVP & President Cardiovascular
Officer
|
1,594
-2.0%
85.06
USD 135,586
|
1,594
-2.0%
|
85.06
|
USD 135,586
|
|
|
2023-12-20 |
2023-12-19 |
PS
Planned sale
|
Wall Brett A.
EVP & Pres Neuroscience
Officer
|
4,997
-14.7%
82.17
USD 410,603
|
4,997
-14.7%
|
82.17
|
USD 410,603
|
|
|
2023-08-25 |
2023-08-23 |
S
Sale
|
Smith Gregory L
EVP Global Ops & Supply Chain
Officer
|
10,000
-17.6%
83.84
USD 838,400
|
10,000
-17.6%
|
83.84
|
USD 838,400
|
|
|
2023-08-16 |
2023-08-14 |
PS
Planned sale
|
Wall Brett A.
EVP & Pres Neuroscience
Officer
|
1,000
-2.9%
83.38
USD 83,380
|
1,000
-2.9%
|
83.38
|
USD 83,380
|
|
|
2023-08-07 |
2023-08-04 |
PS
Planned sale
|
Marinaro Michael
EVP & President, Surgical OU
Officer
|
1,352
-4.5%
84.11
USD 113,717
|
1,352
-4.5%
|
84.11
|
USD 113,717
|
|
|
2023-07-18 |
2023-07-14 |
PS
Planned sale
|
Wall Brett A.
EVP & Pres Neuroscience
Officer
|
2,000
-7.7%
87.97
USD 175,940
|
2,000
-7.7%
|
87.97
|
USD 175,940
|
|
|
2023-07-12 |
2023-07-10 |
S
Sale
|
TEN HOEDT ROB
EVP and Pres. Global Regions
Officer
|
3,706
-7.8%
86.58
USD 320,865
|
3,706
-7.8%
|
86.58
|
USD 320,865
|
|
|
2023-07-12 |
2023-07-10 |
S
Sale
|
TEN HOEDT ROB
EVP and Pres. Global Regions
Officer
|
1,808
-4.0%
86.59
USD 156,555
|
1,808
-4.0%
|
86.59
|
USD 156,555
|
|
|
2022-12-16 |
2022-12-13 |
S
Sale
|
Salmon Sean
EVP & President Cardiovascular
Officer
|
16,631
-31.5%
80.50
USD 1,338,736
|
16,631
-31.5%
|
80.50
|
USD 1,338,736
|
|
|
2022-10-17 |
2022-10-14 |
S
Sale
|
TEN HOEDT ROB
EVP and Pres. Global Regions
Officer
|
2,404
-5.2%
81.54
USD 196,015
|
2,404
-5.2%
|
81.54
|
USD 196,015
|
|
|
2022-03-21 |
2022-03-18 |
PS
Planned sale
|
PARKHILL KAREN L
EVP & Chief Financial Officer
Officer
|
682
-1.9%
110.00
USD 75,020
|
682
-1.9%
|
110.00
|
USD 75,020
|
|
|
2022-03-14 |
2022-03-11 |
S
Sale
|
Surface Carol A
SVP, Chief HR Officer
Officer
|
6,000
-17.4%
105.30
USD 631,800
|
6,000
-17.4%
|
105.30
|
USD 631,800
|
|
|
2021-12-17 |
2021-12-16 |
B
Purchase
|
ANDERSON RICHARD H
Non-Executive Director
|
5,010
+4.8%
103.26
USD 517,333
|
5,010
+4.8%
|
103.26
|
USD 517,333
|
|
|
2021-12-07 |
2021-12-06 |
PS
Planned sale
|
PARKHILL KAREN L
EVP & Chief Financial Officer
Officer
|
682
-1.9%
110.00
USD 75,020
|
682
-1.9%
|
110.00
|
USD 75,020
|
|
|
2021-10-01 |
2021-09-30 |
PS
Planned sale
|
Lerman Bradley E
SVP General Counsel & Corp Sec
Officer
|
49,147
-50.2%
126.58
USD 6,221,027
|
49,147
-50.2%
|
126.58
|
USD 6,221,027
|
|
|
2021-08-26 |
2021-08-25 |
S
Sale
|
Salmon Sean
EVP & Pres Diabetes/Cardiovasc
Officer
|
7,290
-17.9%
134.09
USD 977,516
|
7,290
-17.9%
|
134.09
|
USD 977,516
|
|
|
2021-08-26 |
2021-08-25 |
S
Sale
|
Salmon Sean
EVP & Pres Diabetes/Cardiovasc
Officer
|
21,129
-38.8%
134.08
USD 2,832,976
|
21,129
-38.8%
|
134.08
|
USD 2,832,976
|
|
|
2021-08-04 |
2021-08-02 |
PS
Planned sale
|
Lerman Bradley E
SVP General Counsel & Corp Sec
Officer
|
4,000
-7.7%
131.52
USD 526,080
|
4,000
-7.7%
|
131.52
|
USD 526,080
|
|
|
2021-06-17 |
2021-06-15 |
PS
Planned sale
|
PARKHILL KAREN L
EVP & Chief Financial Officer
Officer
|
605
-0.7%
124.47
USD 75,304
|
605
-0.7%
|
124.47
|
USD 75,304
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Wall Brett A.
EVP & Pres Neuroscience
Officer
|
2,473
-10.3%
128.07
USD 316,717
|
2,473
-10.3%
|
128.07
|
USD 316,717
|
|
|
2021-06-01 |
2021-05-28 |
PS
Planned sale
|
Liddicoat John R
EVP & President of Americas
Officer
|
34,656
-44.9%
126.65
USD 4,389,182
|
34,656
-44.9%
|
126.65
|
USD 4,389,182
|
|
|
2021-04-07 |
2021-04-05 |
PS
Planned sale
|
Martha Geoffrey
CEO
Executive Director
|
9,308
-10.2%
118.83
USD 1,106,070
|
9,308
-10.2%
|
118.83
|
USD 1,106,070
|
|
|
2021-04-07 |
2021-04-05 |
PS
Planned sale
|
Martha Geoffrey
CEO
Executive Director
|
2,404
-2.9%
118.83
USD 285,667
|
2,404
-2.9%
|
118.83
|
USD 285,667
|
|
|
2021-03-16 |
2021-03-15 |
PS
Planned sale
|
PARKHILL KAREN L
EVP & Chief Financial Officer
Officer
|
632
-0.7%
119.12
USD 75,284
|
632
-0.7%
|
119.12
|
USD 75,284
|
|
|
2021-03-03 |
2021-03-02 |
S
Sale
|
TEN HOEDT ROB
EVP & President EMEA
Officer
|
7,168
-14.1%
117.98
USD 845,681
|
7,168
-14.1%
|
117.98
|
USD 845,681
|
|
|
2020-12-30 |
2020-12-28 |
S
Sale
|
Surface Carol A
SVP, Chief HR Officer
Officer
|
15,000
-30.5%
114.90
USD 1,723,500
|
15,000
-30.5%
|
114.90
|
USD 1,723,500
|
|
|
2020-12-23 |
2020-12-22 |
S
Sale
|
Lerman Bradley E
SVP General Counsel & Corp Sec
Officer
|
2,605
-4.8%
115.56
USD 301,034
|
2,605
-4.8%
|
115.56
|
USD 301,034
|
|
|
2020-12-21 |
2020-12-18 |
S
Sale
|
WHITE ROBERT JOHN
EVP & Pres. Medical Surgical
Officer
|
10,930
-19.6%
115.46
USD 1,261,978
|
10,930
-19.6%
|
115.46
|
USD 1,261,978
|
|
|
2020-12-16 |
2020-12-15 |
PS
Planned sale
|
PARKHILL KAREN L
EVP & Chief Financial Officer
Officer
|
670
-0.8%
114.33
USD 76,601
|
670
-0.8%
|
114.33
|
USD 76,601
|
|
|
2020-11-10 |
2020-11-09 |
PS
Planned sale
|
Lerman Bradley E
SVP General Counsel & Corp Sec
Officer
|
20,715
-27.7%
113.13
USD 2,343,488
|
20,715
-27.7%
|
113.13
|
USD 2,343,488
|
|
|
2020-10-14 |
2020-10-09 |
S
Sale
|
ISHRAK OMAR
Executive Chairman
Executive Director
|
763
-0.1%
108.40
USD 82,709
|
763
-0.1%
|
108.40
|
USD 82,709
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Lerman Bradley E
SVP General Counsel & Corp Sec
Officer
|
797
-1.4%
110.00
USD 87,670
|
797
-1.4%
|
110.00
|
USD 87,670
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Lerman Bradley E
SVP General Counsel & Corp Sec
Officer
|
19,917
-26.8%
110.00
USD 2,190,870
|
19,917
-26.8%
|
110.00
|
USD 2,190,870
|
|
|
2020-10-09 |
2020-10-08 |
B
Purchase
|
ANDERSON RICHARD H
Non-Executive Director
|
4,607
+4.7%
108.52
USD 499,952
|
4,607
+4.7%
|
108.52
|
USD 499,952
|
|
|
2020-09-25 |
2020-09-23 |
PS
Planned sale
|
TEN HOEDT ROB
EVP & President EMEA
Officer
|
9,584
-18.1%
104.34
USD 999,995
|
9,584
-18.1%
|
104.34
|
USD 999,995
|
|
|
2020-09-16 |
2020-09-15 |
PS
Planned sale
|
PARKHILL KAREN L
EVP & Chief Financial Officer
Officer
|
702
-0.8%
107.78
USD 75,662
|
702
-0.8%
|
107.78
|
USD 75,662
|
|
|
2020-09-11 |
2020-09-09 |
PS
Planned sale
|
TEN HOEDT ROB
EVP & President EMEA
Officer
|
9,563
-15.3%
105.05
USD 1,004,593
|
9,563
-15.3%
|
105.05
|
USD 1,004,593
|
|
|
2020-06-02 |
2020-05-29 |
S
Sale
|
Surface Carol A
SVP, Chief HR Officer
Officer
|
2,000
-4.0%
97.72
USD 195,440
|
2,000
-4.0%
|
97.72
|
USD 195,440
|
|
|
2020-02-24 |
2020-02-20 |
B
Purchase
|
ISHRAK OMAR
Chairman & CEO
Executive Director
|
8,771
+1.5%
113.68
USD 997,087
|
8,771
+1.5%
|
113.68
|
USD 997,087
|
|
|
2019-12-26 |
2019-12-24 |
S
Sale
|
Kuntz Richard
SVP & Chief Medical & Science
Officer
|
38,558
-35.2%
113.56
USD 4,378,646
|
38,558
-35.2%
|
113.56
|
USD 4,378,646
|
|
|
2019-12-26 |
2019-12-24 |
S
Sale
|
Kuntz Richard
SVP & Chief Medical & Science
Officer
|
1,808
-2.5%
113.66
USD 205,497
|
1,808
-2.5%
|
113.66
|
USD 205,497
|
|
|
2019-12-26 |
2019-12-24 |
S
Sale
|
Kuntz Richard
SVP & Chief Medical & Science
Officer
|
2,404
-3.3%
113.60
USD 273,094
|
2,404
-3.3%
|
113.60
|
USD 273,094
|
|
|
2019-12-26 |
2019-12-24 |
S
Sale
|
Kuntz Richard
SVP & Chief Medical & Science
Officer
|
3,019
-4.1%
113.63
USD 343,049
|
3,019
-4.1%
|
113.63
|
USD 343,049
|
|
|
2019-12-26 |
2019-12-24 |
S
Sale
|
Kuntz Richard
SVP & Chief Medical & Science
Officer
|
5,067
-6.4%
113.64
USD 575,814
|
5,067
-6.4%
|
113.64
|
USD 575,814
|
|
|
2019-12-09 |
2019-12-06 |
B
Purchase
|
ANDERSON RICHARD H
Non-Executive Director
|
5,000
+5.5%
113.29
USD 566,450
|
5,000
+5.5%
|
113.29
|
USD 566,450
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
12,583
-19.5%
110.97
USD 1,396,373
|
12,583
-19.5%
|
110.97
|
USD 1,396,373
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
12,859
-16.6%
110.28
USD 1,418,091
|
12,859
-16.6%
|
110.28
|
USD 1,418,091
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
13,240
-14.6%
110.97
USD 1,469,283
|
13,240
-14.6%
|
110.97
|
USD 1,469,283
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
13,484
-12.9%
110.29
USD 1,487,083
|
13,484
-12.9%
|
110.29
|
USD 1,487,083
|
|
|
2019-11-18 |
2019-11-15 |
PS
Planned sale
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Officer
|
3,797
-2.0%
112.07
USD 425,530
|
3,797
-2.0%
|
112.07
|
USD 425,530
|
|
|
2019-11-18 |
2019-11-15 |
PS
Planned sale
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Officer
|
25,710
-11.8%
111.31
USD 2,861,883
|
25,710
-11.8%
|
111.31
|
USD 2,861,883
|
|
|
2019-11-18 |
2019-11-15 |
PS
Planned sale
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Officer
|
7,367
-3.3%
110.59
USD 814,680
|
7,367
-3.3%
|
110.59
|
USD 814,680
|
|
|
2019-11-15 |
2019-11-14 |
PS
Planned sale
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Officer
|
1,202
-0.6%
109.95
USD 132,160
|
1,202
-0.6%
|
109.95
|
USD 132,160
|
|
|
2019-11-15 |
2019-11-14 |
PS
Planned sale
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Officer
|
900
-0.5%
109.52
USD 98,571
|
900
-0.5%
|
109.52
|
USD 98,571
|
|
|
2019-11-04 |
2019-11-01 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
1,964
-3.6%
109.66
USD 215,378
|
1,964
-3.6%
|
109.66
|
USD 215,378
|
|
|
2019-11-04 |
2019-11-01 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
3,349
-5.8%
109.11
USD 365,419
|
3,349
-5.8%
|
109.11
|
USD 365,419
|
|
|
2019-11-04 |
2019-11-01 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
14,662
-22.0%
109.67
USD 1,607,938
|
14,662
-22.0%
|
109.67
|
USD 1,607,938
|
|
|
2019-11-04 |
2019-11-01 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
28,428
-29.9%
109.11
USD 3,101,722
|
28,428
-29.9%
|
109.11
|
USD 3,101,722
|
|
|
2019-11-04 |
2019-11-01 |
PS
Planned sale
|
WHITE ROBERT JOHN
EVP & President MITG
Officer
|
3,762
-6.1%
109.66
USD 412,537
|
3,762
-6.1%
|
109.66
|
USD 412,537
|
|
|
2019-11-04 |
2019-11-01 |
PS
Planned sale
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Officer
|
1,202
-0.6%
109.50
USD 131,619
|
1,202
-0.6%
|
109.50
|
USD 131,619
|
|
|
2019-11-04 |
2019-11-01 |
PS
Planned sale
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Officer
|
37,774
-16.7%
109.50
USD 4,136,253
|
37,774
-16.7%
|
109.50
|
USD 4,136,253
|
|
|
2019-09-30 |
2019-09-27 |
PS
Planned sale
|
Kuntz Richard
SVP & Chief Medical & Science
|
100
-0.1%
108.21
USD 10,821
|
100
-0.1%
|
108.21
|
USD 10,821
|
|
|
2019-09-30 |
2019-09-27 |
PS
Planned sale
|
Kuntz Richard
SVP & Chief Medical & Science
|
21,325
-21.3%
107.51
USD 2,292,672
|
21,325
-21.3%
|
107.51
|
USD 2,292,672
|
|
|
2019-09-12 |
2019-09-10 |
PS
Planned sale
|
HAKAMI HOOMAN
EVP & Group President Diabetes
|
423
-1.4%
107.22
USD 45,354
|
423
-1.4%
|
107.22
|
USD 45,354
|
|
|
2019-09-12 |
2019-09-10 |
PS
Planned sale
|
HAKAMI HOOMAN
EVP & Group President Diabetes
|
14,121
-31.5%
107.41
USD 1,516,765
|
14,121
-31.5%
|
107.41
|
USD 1,516,765
|
|
|
2019-09-12 |
2019-09-10 |
PS
Planned sale
|
HAKAMI HOOMAN
EVP & Group President Diabetes
|
595
-1.9%
107.22
USD 63,796
|
595
-1.9%
|
107.22
|
USD 63,796
|
|
|
2019-09-12 |
2019-09-10 |
PS
Planned sale
|
HAKAMI HOOMAN
EVP & Group President Diabetes
|
19,054
-38.2%
107.41
USD 2,046,666
|
19,054
-38.2%
|
107.41
|
USD 2,046,666
|
|
